Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 as an Early Biomarker for ST Elevation Myocardial Infarction - Time-Dependent Comparison With Other Biomarkers
Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 as an Early Biomarker for ST Elevation Myocardial Infarction - Time-Dependent Comparison With Other Biomarkers
复制标题
DOI:
10.1253/circj.cj-10-0913
复制
发表时间:
2011-06-01
影响因子:
3.3
通讯作者:
Mizuno, Kyoichi
中科院分区:
文献类型:
--
作者:
Kobayashi, Nobuaki;Hata, Noritake;Mizuno, Kyoichi
Background: The diagnostic sensitivity of myocardial necrosis markers, such as creatine kinase-MB (CK-MB), cardiac troponins, myoglobin and heart-type fatty acid-binding protein (H-FABP) for the earliest stage of ST-elevation myocardial infarction (STEMI), remains insufficient. We compared a new biomarker of plague vulnerability (soluble lectin-like oxidized low-density lipoprotein receptor-1, sLOX-1) with other biomarkers at the earliest stage of STEMI.Methods and Results: Plasma sLOX-1 levels were measured in 125 STEMI, 44 non-STEMI (NSTEMI) and 125 non-acute myocardial infarction (non-AMI) patients and were significantly (P= 2 h thereafter. The diagnostic sensitivity of sLOX-1, H-FABP, myoglobin, troponin T and CK-MB for STEMI upon admission (89min after onset) was 93%, 78%, 70%, 56% and 33%, respectively.Conclusions: Plasma sLOX-1 diagnosed the early stages of STEMI more accurately than H-FABP, myoglobin, troponin T and CK-MB. (Circ J 2011; 75: 1433-1439)